Xbiotech Inc Stock Quote | Stock Price for XBIT | FinancialContent Business Page
FinancialContent fully hosted finance channel
Source: financialcontent.com
Stay updated with breaking news from Therapy Discovered. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinancialContent fully hosted finance channel
XBiotech Inc. (NASDAQ: XBIT) has enrolled the first subject in a randomized, open-label, placebo-controlled dose escalation clinical study to evaluate safety and pharmacokinetics of Hutrukin. Hutrukin is being developed as a novel treatment to reduce brain injury following ischemic stroke. There are more than 10 ...
Hutrukin, A Therapy Discovered and Manufactured at XBiotech, Is Aimed to Reduce Brain Injury after StrokeAUSTIN, Texas, April 17, 2023 -- XBiotech Inc. has enrolled the first subject in a... | April 17, 2023